Lacrimal Devices Market Size and Revenue Forecast Analysis to 2033
Author : DheerajV Patil | Published On : 01 Jun 2026
The global lacrimal devices market is witnessing steady growth due to the increasing prevalence of ophthalmic disorders, rising incidence of dry eye syndrome, and growing demand for minimally invasive eye care procedures. The global lacrimal devices market size was valued at USD 155.33 million in 2024 and is anticipated to grow from USD 160.76 million in 2025 to reach USD 211.7 million in 2033, growing at a CAGR of 3.5% during the forecast period (2025–2033).
The market expansion is supported by advancements in ophthalmic technologies, increasing awareness regarding eye health, and growing adoption of lacrimal drainage procedures. Rising healthcare expenditure and improving access to specialized ophthalmic treatments are further contributing to market growth worldwide.
Market Drivers
One of the major factors driving the lacrimal devices market is the increasing prevalence of lacrimal drainage disorders and dry eye syndrome. The growing aging population and rising exposure to digital screens have significantly increased the incidence of eye-related conditions, driving demand for effective treatment solutions.
Another significant growth driver is the rising adoption of minimally invasive ophthalmic procedures. Patients and healthcare providers increasingly prefer advanced lacrimal devices that offer improved treatment outcomes, reduced recovery time, and enhanced patient comfort.
Technological advancements in ophthalmology are also contributing to market growth. Manufacturers are developing innovative stents, intubation sets, and balloon catheter devices that improve procedural efficiency and treatment success rates.
Market Challenges
Despite favorable growth opportunities, the lacrimal devices market faces several challenges. One of the primary restraints is the high cost associated with specialized ophthalmic procedures and advanced lacrimal devices, which may limit accessibility in certain regions.
Another challenge is the shortage of skilled ophthalmologists and trained healthcare professionals capable of performing complex lacrimal procedures, particularly in developing economies.
Additionally, procedural risks, postoperative complications, and stringent regulatory approval requirements may create barriers to market expansion.
Market Segmentation
The lacrimal devices market is segmented based on product type, application, end-user, and procedure type.
By Product Type:
- Lacrimal Stents
- Lacrimal Intubation Sets
- Balloon Catheter Devices
- Cannulas and Tubes
- Others
The lacrimal stents segment holds a significant market share due to increasing adoption in lacrimal drainage procedures and growing demand for long-term treatment solutions.
By Application:
- Dry Eye Syndrome
- Glaucoma
- Lacrimal Gland Inflammation
- Nasolacrimal Duct Obstruction
- Others
The nasolacrimal duct obstruction segment dominates the market owing to the rising prevalence of tear drainage disorders and increasing treatment rates.
By Procedure Type:
- Dacryocystorhinostomy (DCR)
- Intubation Procedures
- Stenting Procedures
- Others
The dacryocystorhinostomy segment accounts for a considerable market share due to its effectiveness in treating blocked tear ducts.
By End-User:
- Hospitals
- Ophthalmology Clinics
- Ambulatory Surgical Centers
Hospitals represent the largest end-user segment due to the availability of advanced ophthalmic infrastructure and specialized healthcare professionals.
Regional Insights
North America dominates the global lacrimal devices market due to advanced healthcare infrastructure, growing prevalence of ophthalmic disorders, and increasing adoption of innovative eye care technologies.
Europe represents a significant market supported by rising healthcare expenditure, increasing awareness regarding eye health, and growing demand for minimally invasive ophthalmic procedures.
Asia-Pacific is expected to witness the fastest growth during the forecast period due to expanding healthcare infrastructure, increasing patient population, and growing access to specialized ophthalmology services.
Latin America and the Middle East & Africa are emerging markets supported by improving healthcare facilities and increasing awareness regarding eye disease diagnosis and treatment.
Key Players Analysis
The lacrimal devices market is highly competitive, with companies focusing on product innovation, strategic collaborations, and geographic expansion to strengthen their market position. Key companies operating in the market include:
- FCI Ophthalmics
- Bess Medical Technology GmbH
- Kaneka Corporation
- Lacrimedics Inc.
- Gunther Weiss Scientific Glassblowing Co., Inc.
- Cook Medical
- Innovia Medical
- BVI Medical
- Rumex International Co.
- Surtex Instruments Limited
These companies continue investing in advanced ophthalmic solutions, minimally invasive treatment technologies, and product portfolio expansion to strengthen their competitive positioning in the global market.
For detailed insights, visit:
https://straitsresearch.com/report/lacrimal-devices-market
About Us
Straits Research is a leading research and intelligence organization specializing in research, analytics, and advisory services, along with providing business insights and comprehensive market research reports across multiple industries.
Contact Us
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
